188 related articles for article (PubMed ID: 25919064)
1. Nanotechnological approaches for the effective management of psoriasis.
Garg T; Rath G; Goyal AK
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1374-82. PubMed ID: 25919064
[TBL] [Abstract][Full Text] [Related]
2. Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis.
Garg T; Rath G; Goyal AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(4):331-64. PubMed ID: 25072198
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology-based Medicinal Products and Patents: A Promising Way to Treat Psoriasis.
Ali F; Neha K; Sharma K; Khasimbi S; Chauhan G
Curr Drug Deliv; 2022; 19(5):587-599. PubMed ID: 35081890
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis.
Weigle N; McBane S
Am Fam Physician; 2013 May; 87(9):626-33. PubMed ID: 23668525
[TBL] [Abstract][Full Text] [Related]
5. An Overview on Promising Nanotechnological Approaches for the Treatment of Psoriasis.
Pandey K; Nimisha
Recent Pat Nanotechnol; 2020; 14(2):102-118. PubMed ID: 32013854
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
7. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
[TBL] [Abstract][Full Text] [Related]
9. Pediatric psoriasis.
Busch AL; Landau JM; Moody MN; Goldberg LH
Skin Therapy Lett; 2012 Jan; 17(1):5-7. PubMed ID: 22358228
[TBL] [Abstract][Full Text] [Related]
10. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
11. Recent Advancements in Novel Formulations of Anti-psoriatic Agents for Effective Delivery: Clinical Importance and Patent Survey.
Dadwal N; Kurmi BD; Singh D; Singh A
Recent Pat Nanotechnol; 2024; 18(3):259-277. PubMed ID: 37264655
[TBL] [Abstract][Full Text] [Related]
12. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
Katare OP; Raza K; Singh B; Dogra S
Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304
[TBL] [Abstract][Full Text] [Related]
13. Types of Psoriasis and Their Effects on the Immune System.
Dhabale A; Nagpure S
Cureus; 2022 Sep; 14(9):e29536. PubMed ID: 36312680
[TBL] [Abstract][Full Text] [Related]
14. Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy.
Gupta R; Gupta M; Mangal S; Agrawal U; Vyas SP
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):825-34. PubMed ID: 25465045
[TBL] [Abstract][Full Text] [Related]
15. Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008.
Takahashi H; Nakamura K; Kaneko F; Nakagawa H; Iizuka H;
J Dermatol; 2011 Dec; 38(12):1125-9. PubMed ID: 21951304
[TBL] [Abstract][Full Text] [Related]
16. How relevant are vascular endothelial growth factor and intercellular adhesion molecule in the systemic capillary leak syndrome of psoriasis?
Bressan AL; Pereira D; Medeiros PM; Carneiro S; Azulay-Abulafia L
An Bras Dermatol; 2017; 92(6):826-829. PubMed ID: 29364440
[TBL] [Abstract][Full Text] [Related]
17. The psoriatic patient profile for infliximab.
Gisondi P; Malara G; Ardigò M
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1445-51. PubMed ID: 22288305
[TBL] [Abstract][Full Text] [Related]
18. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Freeman K
Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
